PAR11- THE LONG-TERM SOCIETAL ECONOMIC AND HUMANISTIC BENEFITS OF TREATING ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS (AECB) WITH GEMIFLOXACIN VERSUS CLARITHROMYCIN
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-34.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71193-7/fulltext
Title :
PAR11- THE LONG-TERM SOCIETAL ECONOMIC AND HUMANISTIC BENEFITS OF TREATING ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS (AECB) WITH GEMIFLOXACIN VERSUS CLARITHROMYCIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71193-7&doi=10.1046/j.1524-4733.2001.40202-34.x
First page :
Section Title :
Open access? :
No
Section Order :
84